- Report
- August 2022
- 104 Pages
From €3045EUR$3,450USD£2,625GBP
- Report
- February 2024
- 202 Pages
Global
From €4413EUR$5,000USD£3,804GBP
- Report
- October 2025
- 80 Pages
Kuwait
From €4281EUR$4,850USD£3,690GBP
- Report
- September 2025
- 96 Pages
Germany
From €4281EUR$4,850USD£3,690GBP
- Report
- January 2025
- 230 Pages
United States
From €3089EUR$3,500USD£2,663GBP
- Report
- July 2024
- 326 Pages
China
From €3531EUR$4,000USD£3,044GBP
- Report
- July 2024
- 90 Pages
China
From €1589EUR$1,800USD£1,370GBP
- Report
- July 2024
- 187 Pages
China
From €1589EUR$1,800USD£1,370GBP
- Report
- September 2023
- 114 Pages
Global
From €2604EUR$2,950USD£2,245GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2604EUR$2,950USD£2,245GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3045EUR$3,450USD£2,625GBP
- Report
- September 2023
- 101 Pages
North America
From €2604EUR$2,950USD£2,245GBP
- Report
- September 2023
- 194 Pages
Global
From €4369EUR$4,950USD£3,766GBP
- Report
- October 2022
- 194 Pages
Global
From €4413EUR$5,000USD£3,804GBP
From €1765EUR$2,000USD£1,522GBP
- Report
- March 2021
- 214 Pages
Global
From €1765EUR$2,000USD£1,522GBP
- Report
- February 2021
- 80 Pages
India
From €1050EUR$1,190USD£905GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,842USD£3,560GBP
- Report
- April 2020
- 182 Pages
Global
From €3531EUR$4,000USD£3,044GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,248USD£3,123GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more